Overview

VivoSense develops digital endpoints from wearable devices to enhance clinical trials. By capturing and processing data from these devices, VivoSense transforms raw sensor information into reliable digital endpoints that provide precise insights into patient health and treatment outcomes. The company serves pharmaceutical companies, biotech firms, and research institutions, offering a comprehensive suite of services that includes data design, collection, cleaning, analysis, and reporting. This end-to-end approach allows clients to gain actionable insights, leading to more effective treatments. VivoSense differentiates itself by focusing on the integration of wearable technology and advanced data analytics, aiming to improve the accuracy and efficiency of clinical trials. The goal is to optimize clinical trials and ultimately enhance patient outcomes.

Simplify's Take

What believers are saying

• Increased adoption of DCTs boosts demand for VivoSense's wearable technology solutions.
• The wearable medical device market is projected to grow significantly by 2030.
• FDA acceptance of digital health technologies supports VivoSense's digital endpoints.

What critics are saying

• Emerging startups in digital health could threaten VivoSense's market share.
• Rapid tech advancements may strain VivoSense's resources for software updates.
• Data privacy concerns could impose additional compliance costs on VivoSense.

What makes VivoSense unique

• VivoSense specializes in digital endpoints from wearable devices for clinical trials.
• The company offers end-to-end services from data collection to analysis and reporting.
• VivoSense focuses on patient-centric digital biomarkers, enhancing trial accuracy and engagement.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$26.3M

Above

Industry Average

Funded Over

2 Rounds

$25,000,000

Series A

Mar 2022

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.

Series A Funding Comparison

Above Average

Industry standards

Ind Avg. $15M

$3.7M

$5M

$8.2M

$15M

$25M

$100M

View all funding stages